Analyst Jasper Hellweg works at ARGUS and is focused on the Healthcare sector with 124 price targets and ratings documented since 2017 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 88.1% with an average time for price targets to be met of 243.21 days.
Most recent stock forecast was given on MRNA, Moderna, Inc at 14-Sep-2022.
Jasper Hellweg best performing recommendations are on MRNA (MODERNA, INC).
The best stock recommendation documented was for MRNA (MODERNA, INC) at 11/11/2020. The price target of $88 was fulfilled within 2 days with a profit of $5.56 (6.74%) receiving and performance score of 33.72.
Average potential price target upside